PiCoVacc

PiCoVacc Uses, Dosage, Side Effects, Food Interaction and all others data.

PiCoVacc, previously known as PiCoVacc, is a SARS-CoV-2 purified, inactivated, and adsorbed vaccine candidate developed by SinoVac Biotech Corporation. It was developed by propagating the SARS-CoV-2 CN2 strain inside Vero Cells and inactivating it with B-propiolactone. In preclinical trials, PiCoVacc induced SARS-CoV-2-specific neutralizing antibodies in rats, mice, and the rhesus macaque. The antibodies were found to neutralize 10 representative SARS-CoV-2 strains. As of August 2020, the vaccine is being tested in numerous human clinical trials assessing its safety and immunogenicity.

Trade Name PiCoVacc
Generic CoronaVac
CoronaVac Other Names PiCoVacc
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PiCoVacc
PiCoVacc

Innovators Monograph

You find simplified version here PiCoVacc

*** Taking medicines without doctor's advice can cause long-term problems.
Share